Tag: ERBB2-negative breast cancer

#VisualAbstract: Delayed receipt of adjuvant hormone therapy is associated with worse survival in HR⁺, ERBB2- breast cancer

byTeddy Guo

March 8, 2022

Click to read this study in JAMA Network Open.

Adjuvant celecoxib not associated with improved disease-free survival in patients with ERBB2-negative breast cancer

byYuchen Daiand1 others

July 23, 2021

1. The study found no evidence of benefit to disease-free survival when 400 mg of celecoxib was administered once daily ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result